SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Closure Medical (CLSR) fomerly Tri-Point Medical (TPMC) -- Ignore unavailable to you. Want to Upgrade?

To: Laurens who wrote (105)2/2/1998 11:13:00 AM
From: David S.  Read Replies (1) | Respond to of 184
 
oppenheimer had comments today - rated hold, market cap=$368 million. Trades above their discounted cash flow valuation of $20.75 per share.
US market opportunity estimated at $22 million in the emergency room setting - (J&J gets a piece of the pie). 1998 eps est = -.49 & the 99 est is positive .08



To: Laurens who wrote (105)2/9/1998 7:52:00 AM
From: JYatsu  Read Replies (1) | Respond to of 184
 
Sorry to reply so late but I've been busy. I don't have any specific place you can get that info. I guess the best place would be the 10Q/K on Edgar. As for recent valuations of the stock by analysts, I believe the market is really missing the point on Dermabond. I believe the bigger utilization will come from the plastic surgeons not the ER.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News